Description of the medicine: Lipostabil (Lipostabil)

LIPOSTABILE (Lipostabil) *.

Complex preparation, manufactured in capsules (forte), containing unsaturated fatty acids (linoleic, linolenic, oleic, total capsule 300 mg) and 7- (b-hydroxyethyl) -theophylline (50 mg in capsule), as well as in ampoules for intravenous Injections with the same acids in the amount of 500 mg, pyridoxine hydrochloride 4 mg, acid nicotine 2 mg; Adenosine-5-monophosphate (AMP) 2 mg.

The hypolipidemic effect of the drug is due to the action of unsaturated fatty acids (see Linetol) and other components. The presence of the theophylline derivative in the capsules may contribute to the antiaggregation effect, and the content of the nicotinic acid and other components in the ampules of the nicotinic and other components is hypolipidemic, although the dose of nicotinic acid in the preparation (2 mg in the ampoule) is small.

It is recommended for use in hypercholesterolemia and hypertriglyceridemia, atherosclerosis, disorders of coronary, cerebral and peripheral circulation, nephrotic syndrome and other diseases associated with hyperlipoproteinemia.

Assign adults 2 capsules (not chew) 3 times daily before meals (with a small amount of water). Course of treatment 1 - 6 months or more.

Into a vein enter (slowly) on 10 - 20 ml (in an ampoule of 10 ml) within 2 - 4 weeks, then pass to supporting therapy (inside on 1-2 capsules 3 times a day).

The drug is usually well tolerated. Intravenously injected without additional dilution. Dissolution of sodium chloride is not allowed. Intramuscular injections are painful.

Forms of release: in capsules in a package of 50 pieces; In ampoules of 10 ml in a package of 5 ampoules.

Storage: in a cool dry place (capsule).